Real-time clinical analytics at scale: a platform built on large language models-powered knowledge graphs. [PDF]
Cao S +5 more
europepmc +1 more source
Data‐Driven Bulldozer Blade Control for Autonomous Terrain Leveling
A simulation‐driven framework for autonomous bulldozer leveling is presented, combining high‐fidelity terramechanics simulation with a neural‐network‐based reduced‐order model. Gradient‐based optimization enables efficient, low‐level blade control that balances leveling quality and operation time.
Harry Zhang +5 more
wiley +1 more source
A Survey on Unifying Large Language Models and Knowledge Graphs for Biomedicine and Healthcare. [PDF]
Xu R +7 more
europepmc +1 more source
Ovarian Matrisome Dynamics and αvβ3‐Mediated Regulation in Early Follicular Development
The matrisome undergoes dynamic remodeling during early follicular development. Integrin αvβ3 mediates matrisome signals, regulating primordial follicle activation/atresia and secondary follicle growth via Hippo/mTOR pathways, with conserved roles in human ovaries, offering therapeutic targets for ovarian disorders.
Tong Wu +12 more
wiley +1 more source
Rendering knowledge graphs from aerospace dentistry processes for clinical decision support systems. [PDF]
Amith MT +6 more
europepmc +1 more source
QBP1 Peptide as a Potential Anti‐Amyloidogenic Therapy for Type 2 Diabetes: An In Vitro Study
The anti‐amyloidogenic peptide QBP1 effectively halts human islet amyloid polypeptide (hIAPP) aggregation, preventing the formation of toxic β‐structured intermediates. Through a combination of biophysical assays, molecular dynamics, and cell‐based studies, QBP1 is shown to preserve β‐cell viability and metabolic homeostasis, positioning it as a ...
María M. Tejero‐Ojeda +8 more
wiley +1 more source
Construction of intelligent decision support systems through integration of retrieval-augmented generation and knowledge graphs. [PDF]
Wang S, Yang H, Bai G.
europepmc +1 more source
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun +23 more
wiley +1 more source
Construction of Personal Health Knowledge Graphs for Clinical Data Harmonization in Breast Cancer
Liang W +15 more
europepmc +1 more source

